🇺🇸 FDA
Patent

US 8410043

Stabilized activin IIB receptor polypeptides and uses thereof

granted A61KA61K38/00A61P

Quick answer

US patent 8410043 (Stabilized activin IIB receptor polypeptides and uses thereof) held by Atara Biotherapeutics, Inc. expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Atara Biotherapeutics, Inc.
Grant date
Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00, A61P, A61P11/00, A61P11/08